National
Romney strong in first debate; LGBT issues not addressed
Obama mentions ‘Don’t Ask’ repeal among accomplishments
LGBT issues were virtually absent in the first debate between President Obama and Mitt Romney (Blade file photo by Michael Key)
Republican presidential nominee Mitt Romney turned in a strong performance in his first debate with President Obama Wednesday night, winning the contest according to most pundits and observers.
The 90-minute debate was virtually devoid of LGBT issues as the candidates clashed over broader economic issues and health care reform.
The most direct reference to LGBT issues came from Obama when he mentioned “Don’t Ask, Don’t Tell” repeal as part of a list of his accomplishments that he achieved through bipartisan effort.
Obama said he’ll “take ideas from anybody, Democrat or Republican” to advance the middle class and that strategy is how the administration passed small business tax cuts, enacted three trade agreements and “how we repealed ‘Don’t Ask, Don’t Tell.'”
Lanae Erickson, director of the social policy and politics program for the centrist advocacy group called Third Way, said she was pleased Obama included “Don’t Ask, Don’t Tell” among his bipartisan initiatives.
“Our country has come a long way when the only time an LGBT issue came up in the first presidential debate was as an example of bipartisanship,” Erickson said. “Obama used repealing ‘Don’t Ask, Don’t Tell’ in a list of things he had done to partner with folks across the aisle — it seems like that would have been unthinkable in 2004, or even 2008.”
Romney made an oblique reference to social issues. He talked about the first line of the Declaration of Independence and protecting “religious tolerance and freedom” in the country, which sometimes has been interpreted as code for support of social conservatives.
But the remark was incidental during the debate as moderator Jim Lehrer — whose performance was immediately savaged by critics — avoided social issues and posed questions on the economy, government programs and tax policy. Questions on LGBT issues weren’t raised — nor anything on other social issues, such as women’s rights or immigration.
Among the major points that came up included Romney saying he’d like to keep certain provisions in financial reform legislation known as Dodd-Frank, such as transparency and leverage limits. Romney also reiterated his pledge to repeal health care reform, but said he supports a policy that keeps insurance companies from discriminating against individuals with pre-exisiting conditions.
Obama and Romney also sparred over tax policy. Obama expressed support for tax cuts for the middle class because “we do best when the middle class is doing well” as he accused Romney of backing a policy that consists of tax cuts for the rich. Romney denied the charge, saying he doesn’t support tax cuts that add to the deficit, prompting Obama to quip, “Well, for 18 months he’s been running on this tax plan. And now, five weeks before the election, he’s saying that his big, bold idea is, ‘Never mind.'”
Jerame Davis, executive director of the National Stonewall Democrats, praised Obama for presenting a starkly different economic plan from Romney’s, saying the president went into more detail than the Republican candidate.
“Mitt Romney came to tonight’s debate prepared to take pot shots at President Obama while dodging questions about the specifics of his vague plans,” Davis said. “In contrast, President Obama addressed the American people directly and laid out a vision for the next four years. Romney’s choices — style over substance, attacks over proposals, platitudes over policies — speak to his character and the type of leader he would be.”
Jimmy LaSalvia, executive director of the gay conservative group GOProud, said Romney won the debate because he laid out greater detail in his proposals.
“Tonight was a very good night for Mitt Romney, a very bad night for Barack Obama, and a very good night for those Americans hungry for a new president and a new direction,” LaSalvia said. “Gov. Romney offered a clear contrast to the failed policies of the last four years. While Gov. Romney offered a new direction, President Obama couldn’t defend his record and offered little in the way of a vision for the future.
Romney also criticized Obama for taking $716 billion from Medicare to pay for expenses in other programs and pledged to reinstate those funds if elected president. This criticism, which has come before from the Republican side, has been roundly panned as a distortion — notably from former President Clinton during his speech at the Democratic National Convention — because the administration redirected those funds to close the donut hole under Medicare to provide prescription drugs for seniors.
John Aravosis, who’s gay and editor of AMERICAblog, took issue with what Romney had to say about Medicare, accusing the Republican candidate of being less than truthful.
“I didn’t like the fact that Romney seemed to trot out a lot of lies, particularly the claim that the president is ‘cutting’ Medicare when Romney’s VP, Paul Ryan, put the president’s Medicare proposal in his own budget,” Aravosis said. “But I also found it creepy that Romney kept saying his Medicare plan would exempt current seniors. If the plan is so good, then why not let current seniors ‘enjoy’ it too?”
Following the debate, many observers concluded Romney won. Obama deputy campaign manager Stephanie Cutter admitted to CNN afterward that “Romney absolutely wins the preparation, and he wins the style points” while adding the Republican candidate’s proposed policies aren’t resonating with the American people.
Dan Pinello, who’s gay and a political scientist at the City University of New York, said Romney won the debate, but only by presenting positions that were different from those on which he campaigned previously.
“Romney had the more animated performance in the debate, while Obama was more cautious,” Pinello said. “But Romney appeared to depart from important policy positions he’d taken during the primary campaign, not to mention his departures from Paul Ryan’s budget. So the debate winner was the New Mitt Romney, a person different from the one who had been the Republican nominee prior to Oct. 3. The loser, however, appeared to be the Republican Party’s base.”
R. Clarke Cooper, executive director of the Log Cabin Republicans, attributed the perception that Romney came out on top to the lack of social issues in the debate.
“One thing came through loud and clear tonight, and we hope our fellow Republicans take note: In a domestic debate without divisive and distracting social issues, conservative ideas resonate, moderates and independents listen, and the Republican wins,” Cooper said.
But Lehrer bore the brunt of criticism from observers. The candidates often ignored him and kept talking after he informed them their time had expired and was seen as asking questions that were too general.
Aravosis said he’s “not thrilled” LGBT rights didn’t come up in a debate about domestic policy, although he acknowledged there’s an opportunity for them to come up in subsequent debates, adding of the debate, “Was there a moderator? I didn’t notice.”
Davis also said Lehrer’s “poor moderation overshadowed the night” as well as Romney’s behavior, but blamed the Republican candidate for being unfairly harsh in demanding more time to speak.
“Knowing that Romney bullied a gay teen during prep school helps to explain his churlish behavior at tonight’s debate,” Davis said. “Instead of looking presidential, Romney appeared to be nothing more than a belligerent schoolyard bully.”
The next debate will be between the No. 2 candidates on the tickets — Vice President Joseph Biden and Republican vice presidential nominee Paul Ryan — and will take Oct. 11 in Danville, Ky. Following that, two more presidential debates will take place: a town-hall style debate on domestic and foreign policy in Hempstead, N.Y., on Oct. 16 and a foreign policy debate in Boca Raton, Fla., on Oct. 22.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Rush reopens after renewing suspended liquor license
Few transgender people benefit from India’s low-income housing program
Exciting electrics: Hyundai Ioniq 5, Volkswagen ID.4
Child- and pet-proofing your home for the holidays
‘Dogs of Venice’ looks at love lost and rediscovered
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
2026 elections will bring major changes to D.C. government
Kazakh Senate approves anti-LGBTQ propaganda bill
New queer bar Rush beset by troubles; liquor license suspended
-
Politics5 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia5 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Opinions4 days ago
2026 elections will bring major changes to D.C. government
-
Kazakhstan4 days ago
Kazakh Senate approves anti-LGBTQ propaganda bill
